Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|March 31, 2005
Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight womenClaudine A Blum, Beat Müller, Peter Huber, et al.Swiss Medical Weekly|July 25, 2019
Estimation of treatment allocation in a randomised, double-blinded, placebo-controlled trialMilica Popovic, Nicole Cesana-Nigro, Bettina Winzeler, et al.The European Respiratory Journal|July 30, 2016
Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumoniaSebastian A Wirz, Claudine A Blum, Philipp Schuetz, et al.Clinical Diabetes and Endocrinology|January 27, 2024
Treatment of glucocorticoid- induced hyperglycemia in hospitalized patients - a systematic review and meta- analysisTristan Struja, Neele Nitritz, Islay Alexander, et al.European Journal of Neurology|July 6, 2026
Diagnostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in Differentiating Primary From Serious Secondary HeadacheSara-Jessica Camerin, Cihan Atila, Claudine A Blum, et al.Plos One|June 10, 2014
Association of adrenal function and disease severity in community-acquired pneumoniaCornelia Mueller, Claudine A Blum, Michael Trummler, et al.Ophthalmology and Therapy|January 12, 2023
Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment AspectsJustus G Garweg, Claudine A Blum, René-Pierre Copt, et al.The European Respiratory Journal|December 23, 2018
Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trialsFahim Ebrahimi, Carole Wolffenbuttel, Claudine A Blum, et al.BMC Endocrine Disorders|January 6, 2022
Glucose control after glucocorticoid administration in hospitalized patients - a retrospective analysisFranzisca Merkofer, Tristan Struja, Neele Delfs, et al.BMC Pulmonary Medicine|December 11, 2023
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trialClaudine A Blum, Eva A Roethlisberger, Nicole Cesana-Nigro, et al.Pageof 4